Contemporary Options for the Management of Motor Complications in Parkinson's Disease: Updated Clinical Review.

Author: CabreiraVerónica, MassanoJoão, Soares-da-SilvaPatrício

Paper Details 
Original Abstract of the Article :
Parkinson's disease (PD) is a chronic, progressive condition affecting around 1% of the population older than 60 years. Upon long-term treatment with levodopa, the mainstay of treatment in PD, most patients, especially younger ones exposed to higher doses, will experience symptoms related to end-of-...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1007/s40265-019-01098-w

データ提供:米国国立医学図書館(NLM)

Parkinson's Disease: Managing Motor Complications

Parkinson's disease (PD) is a progressive neurological disorder that affects movement. As PD progresses, patients often experience motor complications, such as end-of-dose deterioration (symptoms returning before the next dose), peak-dose dyskinesias (involuntary movements), and other fluctuations in motor function. This comprehensive review explores the current treatment options for managing these motor complications, including both traditional and newer therapies.

New Strategies for Managing Motor Complications

The review highlights the evolving understanding of PD's pathophysiology, leading to a growing arsenal of therapeutic approaches. Strategies focus on modifying the pharmacokinetics of levodopa, the mainstay of PD treatment, to extend its benefits. New drug delivery methods, such as levodopa/carbidopa intestinal gel infusion, and long-acting formulations of existing dopaminergic drugs are also being explored. The review also examines the role of non-dopaminergic agents that target other brain regions involved in motor function, such as those acting on glutamate, GABA, serotonin, and calcium channels. The review emphasizes the need for personalized treatment strategies, tailoring therapy to each patient's individual needs.

Improving Quality of Life for Parkinson's Patients

This review provides a valuable resource for healthcare professionals involved in the management of PD. By understanding the evolving landscape of treatment options, clinicians can develop personalized strategies to effectively manage motor complications and improve the quality of life for patients with PD.

Dr.Camel's Conclusion

Treating Parkinson's disease is like a long and arduous journey through a vast desert. This comprehensive review provides a map of the latest therapeutic options, guiding clinicians through the ever-changing landscape of PD treatment. The goal is to help patients navigate the challenges of motor complications and improve their quality of life.

Date :
  1. Date Completed 2019-11-27
  2. Date Revised 2020-02-25
Further Info :

Pubmed ID

30905034

DOI: Digital Object Identifier

10.1007/s40265-019-01098-w

Related Literature

Article Analysis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.